| Welcome to Back Pain Treatment
— your comprehensive back pain treatment resource. Our
mission is to give you the facts you need about back pain treatment
— fast — so you can get on the road to taking
action right away`.
The Back Pain Treatment website
provides a ton of information about back pain treatment.
In addition, you will find extensive information on leading
back pain treatment to help you on your way to success.
Please have a look at our back pain treatment articles,
products, resources, and additional information located
throughout Back Pain Treatment.
We strive to provide only quality articles, so if there
is a specific topic related to back pain treatment that you
would like us to cover, please contact us at any time.
And again, thank you to those contributing daily to our
back pain treatment website.
Spoonful of Sugar Debunked as Baby Painkiller (CME/CE)
(MedPage Today) -- Sugar given to blunt pain in newborns undergoing invasive procedures may only mask signs of distress, researchers found.
Marijuana Eases Neuropathic Pain (CME/CE)
(MedPage Today) -- Smoking marijuana modestly reduced pain and other symptoms of chronic neuropathic pain, results of a small randomized, placebo-controlled trial showed.
Migraine Raises Long-Term CV Risks (CME/CE)
(MedPage Today) -- Patients who have migraine headaches face heightened long-term risks of cardiovascular disease and death, according to analyses of outcomes from two large cohort studies.
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia
BETHESDA, Md. (MedPage Today) -- A federal advisory panel has voted 20-2 to recommend that the FDA not grant approval for an expanded indication for sodium oxybate (Xyrem) -- also known as GHB -- to treat fibromyalgia.
FDA Panel Looks at CNS Depressant for Fibromyalgia
BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.
Equivocal Message on Duloxetine for Pain from Panel
BETHESDA, Md. (MedPage Today) -- An FDA advisory committee has voted narrowly -- 8 to 6 -- to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.
Disparities Exist in Management of Chronic Pain (CME/CE)
(MedPage Today) -- Assessment and treatment of chronic pain in the primary care setting appears to be suboptimal for blacks and women, researchers found.
Tai Chi Relieves Fibromyalgia (CME/CE, with video)
(MedPage Today) -- The mind-body activity of tai chi improved the symptoms of fibromyalgia without any safety concerns, a single-center, randomized controlled trial showed.
Early Palliative Care Boosts Survival in NSCLC (CME/CE, with video)
(MedPage Today) -- Patients with advanced lung cancer lived longer and with a better quality of life when they received early palliative care as opposed to routine care, results of a randomized trial showed.
FDA Panel to Consider Pain Indication for Antidepressant
WASHINGTON (MedPage Today) -- An FDA advisory committee will meet later this week to review whether the antidepressant duloxetine (Cymbalta) should be used as a treatment for chronic pain despite risks that include liver damage and skin disease.
Sham Acupuncture Matches the Real Thing in Knee OA (CME/CE)
(MedPage Today) -- Traditional Chinese acupuncture was no more effective than sham acupuncture in relieving pain in patients with osteoarthritis of the knee, researchers said.
Steroid Shots Soothe Some Sciatica (CME/CE)
(MedPage Today) -- Injection of steroids into the affected spinal nerve appears to ease lumbar radicular pain better than other types of injections, but still in only a proportion of patients, according to a randomized trial.
Diagnostic Nerve Blocks Costly -- and Controversial (CME/CE)
(MedPage Today) -- While some guidelines recommend two diagnostic nerve blocks before radiofrequency treatment for chronic low back pain, a randomized trial showed greater success without use of the prior blocks.
FDA Panel Wants Tougher Restrictions on Opioids
ADELPHI, Md. (MedPage Today) -- An FDA advisory committee voted 25-10 to reject the agency's proposed plan to prevent inappropriate prescribing, misuse, and abuse of extended-release opioid painkillers, saying the plan lacks the teeth to stem the "public health crisis" of opioid addiction, overdose, and death.
Panel to Vote on FDA Proposal on Painkiller Abuse
WASHINGTON (MedPage Today) -- An FDA advisory panel will meet this week to vote on whether to adopt a new risk-reduction strategy for long-acting opioid-based painkillers, the use -- and misuse -- of which have exploded in recent years.
|
